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Abstract
Background With the advent of magnetic resonance imaging
(MRI) conditional pacemaker systems, the possibility of
performing MRI in pacemaker patients has been introduced.
Besides for the detailed evaluation of atrial and ventricular
volumes and function, MRI can be used in combination with
body surface potential mapping (BSPM) in a non-invasive
inverse potential mapping (IPM) strategy. In non-invasive
IPM, epicardial potentials are reconstructed from recorded
body surface potentials (BSP). In order to investigate whether
an IPM method with a limited number of electrodes could be
used for the purpose of non-invasive focus localization, it was
applied in patients with implanted pacing devices. Ventricular
paced beats were used to simulate ventricular ectopic foci.
Methods Ten patients with an MRI-conditional pacemaker
system and a structurally normal heart were studied. Patient-
specific 3D thorax volume models were reconstructed from
the MRI images. BSP were recorded during ventricular pac-
ing. Epicardial potentials were inversely calculated from the
BSP. The site of epicardial breakthrough was compared to the
position of the ventricular lead tip on MRI and the distance
between these points was determined.
Results For all patients, the site of earliest epicardial depolar-
ization could be identified. When the tip of the pacing lead
was implanted in vicinity to the epicardium, i.e. right ventric-
ular (RV) apex or RVoutflow tract, the distance between lead
tip position and epicardial breakthrough was 6.0±1.9 mm.
Conclusions In conclusion, the combined MRI and IPM
method is clinically applicable and can identify sites of earliest
depolarization with a clinically useful accuracy.
Keywords Non-invasive imaging . Inverse potential
mapping . Body surface potential mapping .
Computational cardiac electrophysiology .
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Abbreviations
BSP Body surface potentials
BSPM Body surface potential mapping
CRT Cardiac resynchronization therapy
CT Computed tomography
ECG Electrocardiogram
ECGI Electrocardiographic imaging
EP Electrophysiological
IPM Inverse potential mapping
LV Left ventricle
MRI Magnetic resonance imaging
NICE Non-invasive imaging of cardiac electrophysiology
RV Right ventricle
RVOT Right ventricular outflow tract
SSFP Steady state free precession
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1 Introduction
Invasive electrophysiological procedures are often complicat-
ed by considerable fluoroscopic time, non-inducibility of the
arrhythmia or hemodynamic instability of the patient [1].
Therefore, pre-procedural and non-invasive localization of ar-
rhythmogenic foci may improve the clinical outcome and re-
duce the duration of the invasive procedures [2].
To this intent, over the last decade various non-invasive
mapping strategies, e.g. electrocardiographic imaging
(ECGI) [3], non-invasive imaging of cardiac electrophysi-
ology (NICE) [4] and AMICARD [5] have been intro-
duced. Despite numerous reports on the possible advan-
tages of non-invasive mapping, this approach has not yet
advanced into daily clinical practice as a routine tool. This
is either due to the impracticability associated with the use
of up to 254 torso electrodes or to the limited data available
from in vivo studies with respect to the accuracy and va-
lidity of the estimated epicardial potentials or intramural
activation times.
With the advent of magnetic resonance imaging (MRI)
conditional pacemaker systems, the possibility of performing
MRI in pacemaker patients has been introduced [6]. Besides
for the detailed evaluation of atrial and ventricular volumes
and function, MRI can be used in combination with body
surface potential mapping (BSPM) in a non-invasive inverse
potential mapping (IPM) strategy.
This pilot study investigated the feasibility of non-invasive
focus localization using a limited number of 62 electrodes in
patients with an implanted MRI-conditional pacemaker sys-
tem. Ventricular paced beats were used to simulate ectopic
foci. The estimated site of earliest epicardial breakthrough
was compared to the position of the ventricular lead tip, and
the distance between these sites was determined.
2 Methods
2.1 Patient selection
Inverse potential mapping was performed in ten male patients
(mean age 64±5 years old) with an implanted MRI-
conditional DDD pacemaker system (Advisa MRI™
Surescan®, Medtronic Inc., Minneapolis, MN, USA) and a
structurally normal heart. Patient characteristics are provided
in Table 1.
The study complied with the declaration of Helsinki and
received approval from the local ethical committee and the
institutional scientific board. Written informed consent was
obtained from all patients.
An overview of the complete workflow is provided in
Fig. 1.
2.2 Body surface potential mapping
Body surface potentials (BSP) were recorded using a 65-
channel (62 torso+3 limb electrodes) ActiveTwo BSPM sys-
tem with passive electrodes and shielded cables (BioSemi BV,
Amsterdam, The Netherlands). The BSP electrodes were po-
sitioned on the anterior thorax using a 20-mm inter-electrode
distance (Fig. 1d) [7]. BSP were recorded in supine position at
a sampling rate of 2048 Hz for 10 s during right ventricular
(RV) pacing at a rate exceeding the intrinsic rate with at least
15 beats per minute (paced AV-delay 70 ms).
2.3 Magnetic resonance imaging
After BSPM, MRI markers were applied to replace all torso
electrodes. These markers were used to locate the electrode
positions on the MRI images, thereby minimizing the system-
atic error in the inverse procedure. Before entering the MRI
room, pacing thresholds, P- and R-wave amplitude, and lead
impedance were determined and the pacemaker system was
programmed into MRI SureScan® mode [8].
In order to control lung volume, breath holding was prac-
ticed with the patient prior to the examination. A stack of
ECG-triggered, T2-weighted, bright blood images (slice
thickness, 6 mm) was acquired to record the anatomy of the
thorax and register the position of the RV lead tip and torso
electrodes. Subsequently, cardiac function was assessed using
steady state free precession (SSFP) short-axis, three- and four-
chamber cines (slice thickness, 6 mm, temporal resolution
<50 ms). All images were obtained during breath-hold on a
Siemens Aera 1.5 Tesla MRI scanner (Siemens Healthcare,
Erlangen, Germany). Cardiac function was analysed using
CMR42® software (Circle Cardiovascular Imaging, Calgary,
Alberta, Canada).
After the examination, pacing thresholds, P- and R-wave
amplitude and lead impedance were determined and com-
pared to the initial values. Finally, original programming of
the pacemaker was restored.
2.4 Data processing
2.4.1 3D thorax model
For every patient, a detailed anatomical thorax model, includ-
ing a 3D whole-heart model, was constructed from the MRI
images. Thoracic structures including the heart with all four
compartments, lungs, liver and spleen were manually seg-
mented directly in 3D using custom-written software. Con-
ductivities were assigned to each of these structures as known
from literature (thorax, 0.2 S/m; lungs, 0.04 S/m; liver, 0.03 S/
m and spleen, 0.04 S/m) [9]. A triangulated 3D thorax model
was reconstructed using Gmsh software [10].
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2.4.2 Inverse computation
For each patient, a single paced beat within the 10-s acquisi-
tion window was selected for inverse computation. The elec-
trograms do not require any specific editing prior to process-
ing. Epicardial potentials (Pepi) were calculated from the re-
corded body surface potentials (Pbs) using Pepi=(T
T T+λ2 I)−1
TT Pbs where T is the forward transfer matrix and λ is the
regularization strength (0.01). Finally, an epicardial potential
map of a single paced ventricular beat was reconstructed.
2.4.3 Ventricular lead tip position and the site of earliest
depolarization
An investigator (PB), blinded to the actual ventricular lead tip
position, identified the site of earliest depolarization on the
Table 1 Patient characteristics
Patient Age
(years)
Pacing indication PR
(ms)
QRS
(ms)
QTc
(ms)
Relevant comorbidity
1 66 Asystole 138 102 399 Hypertension
2 42 Asystole 148 96 363 Hemochromatosis
3 64 Bradycardia 180 94 384 Hypercholesterolemia
4 69 AV-block 190 180 380 -
5 70 AV-block 216 150 427 -
6 61 SSS + AV-block 314 128 411 Hypertension
7 69 AV-block 204 169 474 –
8 54 Chronotropic Incompetence 204 98 424 Paroxysmal AF
9 65 SSS 268 100 395 –
10 79 Bradycardia 227 126 380 –
SSS sick sinus syndrome
Fig. 1 Complete workflow (a–f) for a non-invasive IPM procedure
J Interv Card Electrophysiol
colour-coded epicardial potential map. Subsequently, the dis-
tance between this site and the position of the ventricular lead
tip on the MRI images was determined.
2.4.4 Correlation
In order to evaluate the reproducibility of the applied IPM
method, two different paced beats were analysed for each
patient. The epicardial potential distribution was reconstructed
independently. Subsequently, the correlation between the epi-
cardial potentials estimated from the two different beats was
calculated using custom-written software.
2.4.5 Computing platform
Results are shown as mean±SD and are expressed as absolute
values. All analyses were performed on a 2.4-GHz quad core
laptop running theWindows 8 OS. Solving the potential equa-
tions was delegated to an Ubuntu 12.10 virtual machine run-
ning on this laptop.
3 Results
The BSP recording andMRI examination lasted approximately
60 min. None of the patients reported any complaints during or
after the MRI examination. Pacing thresholds and leads imped-
ances remained unaffected by the MRI scan in all patients.
Despite the presence of a pacemaker, image quality was
good to excellent in all patients and allowed for left and right
ventricular function assessment (Fig. 2, panels A, C and E).
MRI-derived global function measures are listed in Table 2.
Figure 2 (panels B, D and F) provides typical examples of
MRI images used to identify the position of RV lead and the
RV lead tip.
3.1 Potential maps
Epicardial potentials were inversely reconstructed and the dis-
tribution was visualized using potential maps. For all patients,
the site of earliest ventricular depolarization could be identi-
fied. Figure 3 shows three typical examples of the potential
distributions reconstructed from the BSP recorded during pac-
ing from different locations.
In two patients (patients 4 and 8), depolarization started in
the superior part of the right ventricular septum. A rapid sub-
sequent depolarization of the right ventricular free wall was
observed (video 1).
In two patients (patients 1 and 2), the site of earliest depo-
larization was located in the apical region of the right ventri-
cle. From that point, depolarization spread rapidly to the basal
portion of both the RVand left ventricle (LV) (video 2).
3.2 Localization
In patients with the tip of the pacing lead close to the epicardium
(apex or right ventricular outflow tract), the distance between
lead tip position and epicardial breakthrough was 6.0±1.9 mm.
For the patients with the tip of the pacing lead implanted in
the middle of the mid-ventricular septum, the observed site of
epicardial breakthrough varied substantially across the right
ventricular free wall. In these patients, the intrinsic distance
from the lead tip to the epicardium was relatively large (range,
5–30 mm). This distance contributes significantly to the mea-
sured localization error (range, 11–45 mm).
3.3 Correlation
In all patients, a high correlation (r=0.97–0.99, p<0.001) be-
tween the epicardial potential distributions of two different
paced beats was calculated (Table 3). Correlation values were
visualized using correlation maps (Fig. 4).
Fig. 2 Left panel, end-diastolic frames from four-chamber (A), short-axis
(C) and three-chamber (E) steady state free precession (SSFP) CINE
images. Despite regional artefacts, caused by either the impulse
generator or the pacing leads, the image quality allows for accurate
assessment of LV and RV volumes and function. LA left atrium, LV left
ventricle, RA right atrium, RV right ventricle, Ao aorta. Right panel, three
examples (B, D and F) of the T2-weighted, bright blood images used to
localize the RV pacing lead (white arrows). The asterisks indicate the
MRI markers that represent the location of the BSP electrodes
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4 Discussion
This is one of the first in vivo studies in patients with an MRI-
conditional pacemaker system, in which a combinedMRI and
IPM approach was applied to non-invasively determine the
origin and epicardial potential distribution during pacing. In
patients with the tip of the pacing lead close to the epicardium,
a localization error of 6.0±1.9 mm was found.
This clinically relevant accuracy and the less cumbersome
nature of the present IPM method may facilitate non-invasive
localization of ectopic ventricular foci in patients suffering
from ventricular arrhythmia prior to entering the catheteriza-
tion suite.
In addition, this offers the prospect of thoroughly investi-
gating in vivo electrical and mechanical activation patterns in
patients with an implanted MRI-conditional pacemaker
system.
4.1 Novelty of this work
4.1.1 IPM in patients with MRI-conditional pacemaker
systems
To our knowledge, this is one of the first reports on the appli-
cation of IPM in patients with implanted MRI-conditional
pacemaker systems. Most validation studies on non-invasive
mapping were performed in animal hearts using computed
tomography (CT) or in humans during conventional electro-
physiological studies [11–14].
In the past, a limited number of patients with an implanted
pacemaker have been studied for validation purposes. In these
studies, ECGI uses 254 torso electrodes and CT images to
calculate epicardial potentials. In only one patient with an
implanted cardiac resynchronization therapy (CRT) device, a
localization error of 7 mm for the RV pacing lead and 11 mm
for the LV lead has been reported [15].
NICE uses 65 electrodes andMRI images to estimate endo-
and epicardial activation times. NICE has been applied in ten
patients with an implanted CRT device [16] and in one patient
with a CRT device and a quadripolar LV lead [17]. No
Table 2 MRI parameters
Patient LVEDV
(ml)
LVESV
(ml)
LVSV
(ml)
LVEF
(%)
RVEDV
(ml)
RVESV
(ml)
RVSV
(ml)
RVEF
(%)
1 147 60 87 59 145 55 91 62
2 133 66 67 50 172 104 69 40
3 135 73 63 46 153 94 58 38
4 193 114 79 41 151 85 66 44
5 153 89 63 41 163 107 55 34
6 175 75 100 57 165 80 86 54
7 187 108 80 43 150 85 66 44
8 157 72 84 54 209 122 87 42
9 177 92 85 48 160 90 70 44
10 113 58 55 48 166 111 55 33
LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, LVSV left ventricular
stroke volume, LVEF left ventricular ejection fraction, RVEDV right ventricular end-diastolic volume, RVESV
right ventricular end-systolic volume, RVSV right ventricular stroke volume, RVEF right ventricular ejection
fraction
Fig. 3 RV lead tip position and site of earliest depolarization on the
potential maps. Pacing from the RV apex (A and B), high in the mid-
ventricular septum (C andD) and right ventricular outflow tract (E and F)
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localization errors could be determined in these studies. Due
to the non-MRI compatibility of the devices used, the MRI
scan was performed prior to implantation of the device,
whereas BSP were recorded after implantation. Hence, co-
registration of the device, the anatomy of the patients and torso
electrodes was not performed.
Recently, Revishili et al. [18] demonstrated the accuracy of
a novel non-invasive epi- and endocardial electrophysiology
system (NEEES) in 29 patients with implanted devices (26
CRT devices in three dual-chamber pacemakers). The mean
distance from the non-invasively predicted pacing site to the
anatomic reference site was 10.8±5.4 mm for the right atrium,
7.7±5.8 mm for the right ventricle and 7.9±5.7 mm for the left
ventricle. However, the authors state that members processing
the NEEES data were not completely blinded for the exact
position of each pacing lead on the available CT images.
4.1.2 Anterior concentrated electrodes
In this study, all BSP electrodes were positioned in a matrix,
directly overlaying the heart. By concentrating the electrodes,
a localization error of 6.0±1.9 mmwas found for patients with
the tip of the pacing lead close to the epicardium. The rapid
positioning of this electrode array may facilitate the incorpo-
ration of this technique in clinical practice.
4.1.3 Epicardial potentials
Currently, only epicardial potentials can be reconstructed from
the recorded BSP. Reconstruction of both epicardial and en-
docardial activation would require the application of an a
priori activation model (e.g. NICE, NEEES). Use of a priori
models mandates various assumptions to be made and limits
the number of pathology related activation patterns that can be
represented.
As described previously by Rudy and co-workers, epi-
cardial potentials contain information on intramural and
endocardial activation even before the epicardium is acti-
vated [19]. Epicardial potentials of the complete cardiac
cycle can be non-invasively reconstructed and isochrones
or activation times can be derived form the reconstructed
potentials [20].
Table 3 Distance epicardial focus to lead tip and correlation between
two different paced beats
Patient Position RV
lead tip
Distance epicardial
focus to lead tip (mm)
Correlation
(r)
1 Apex 4 0.996
2 Apex 5 0.997
3 Mid-septum 45 0.978
4 RVOT 6 0.997
5 Mid-septum 20 0.995
6 Infero-septum 25 0.979
7 Mid-septum 11 0.999
8 RVOT 9 0.994
9 Infero-septum 13 0.999
10 Mid-septum 43 0.966
Fig. 4 Three examples of
intervals selected for correlation
analysis (left panel) and the
corresponding correlation maps
(right panel). In all patients, a
high correlation (r=0.97–0.99,
p<0.001) between the epicardial
potential distribution of two
different paced beats was found
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In patients with implanted pacing devices, visualization
of epicardial activation may provide additional insight in-
to the efficacy of the pacing strategy. Changes in depolar-
ization or repolarization or other signs of adverse pacing
effects may be detected at an early stage. Various studies
have demonstrated that long-term ventricular pacing may
have various unintended adverse electrophysiological and
mechanical effects [21, 22]. In order to better understand
the underlying (patho-) physiological mechanisms, it is
important to further develop clinically applicable, non-
invasive techniques that facilitate an integrated electro-
mechanical assessment.
4.1.4 MRI
Using MRI as a reference for the RV lead tip position is a
novelty. The introduction of MRI-conditional pacemaker sys-
tems enables the use of MRI for IPM. Unlike CT, MRI is not
associated with radiation exposure. MRI-conditional devices
can be programmed in an MRI safe mode, which makes the
device less susceptible to the magnetic energy of the MRI envi-
ronment and decreases the risk of hard- or software interactions.
Besides visualizing the lead position,MRImay provide valu-
able information on the mechanical activation in patients with
implanted pacemaker systems. In contrast to CT, MRI enables
the safe performance of follow-up studies. In addition, MRI is
the gold standard for the detailed assessment of atrial and ven-
tricular volumes, function and wall motion abnormalities [23].
Moreover, the presence and the extent of myocardial scar tissue
can be determined, which may influence cardiac electrical acti-
vation patterns and may impact the effects of pacing [24].
The presence of an implanted device generates image
artefacts that may compromise image quality. By adapting
the scan strategy, the amount of artefacts produced by the
implanted pacemaker system can be kept at a minimum
[25]. Ventricular function is usually assessed in the short-
axis view. These images are mildly affected by the distor-
tion caused by the presence of a pacemaker. Left and right
ventricular function could be assessed for all patients in
this study.
4.2 Limitations of the study
The site of epicardial breakthrough on the epicardial potential
map was compared to the position of the ventricular lead tip
on MRI and the distance between these points was deter-
mined. The position of the RV lead tip was determined using
the susceptibility artefact caused by the lead tip on the MRI
images (Figs. 2 and 3). Alternatively, CT may be used for this
purpose. Nevertheless, the scattering of radiation causes the
overall image quality to decline. In addition, the metallic arte-
fact caused by the lead will hamper the localization of the tip
of lead [26].
For several patients, the reported distance from the lead
tip to the site of earliest depolarization on the epicardial
potential maps includes the distance from the lead tip in the
septum to the epicardium. Septal insertion of the lead tip
increases the intrinsic distance from the lead tip to the site
of epicardial breakthrough. This is a limitation of the re-
construction of epicardial potentials. Therefore, the locali-
zation accuracy is probably severely underestimated in this
group of patients.
The anterior concentration of BSP electrodes does not
allow for accurate investigation of depolarization on the
posterior wall. This pilot study focussed on investigating
the feasibility of performing IPM in patients with an
implanted MRI-conditional pacemaker system. The cur-
rent research did not describe the accuracy of localizing
foci in the inferior wall of the RVor LV. Atrial stimuli were not
analysed in the current study.
It has been shown that prematurity of ectopic foci can affect
cardiac activation patterns. This was not explored in this cur-
rent study by introducing different coupled extra-stimuli dur-
ing RV pacing.
The accuracy of localizing epicardial breakthrough may be
affected by extensive scar in patients with prior infarction or
severe cardiomyopathy. For this reason and in consideration
of the limited size of the study population, additional research
needs to be performed to further explore the clinical benefit of
IPM in combination with MRI in patients suffering from a
wide range of pathologies.
5 Conclusion
In this study, an IPM method using a limited number of elec-
trodes was applied in patients with an MRI-conditional pace-
maker system. For all patients, the epicardial potential distribu-
tion could be reconstructed from BSP recorded during pacing.
In patients with the tip of the pacing lead close to the epicardi-
um, a localization accuracy of 6.0±1.9 mm was found. Appli-
cation of this method in patients suffering from ventricular ar-
rhythmia may enable accurate non-invasive localization of ec-
topic ventricular foci prior to entering the catheterization suite.
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